<DOC>
	<DOCNO>NCT00818792</DOCNO>
	<brief_summary>Percutaneous coronary intervention ( PCI ) bare metal stent ( BMS ) patient renal insufficiency show unsatisfactory result . Indeed , drug-eluting stent ( DES ) might reduce incidence restenosis therefore target lesion revascularization procedures patient . We therefore design prospective , randomize , multicenter , not-sponsored study directly compare efficacy prevention clinical restenosis everolimus-eluting stent ( Xience V ) bare-metal stent ( Vision ) ( 2nd-generation DES BMS , respectively ) , implanted patient multivessel disease renal insufficiency order obviate multiple unpredictable characteristic high-risk population .</brief_summary>
	<brief_title>Randomized Comparison xiEnce visioN Coronary Stents sAme muLtivessel Patient With Chronic kiDnEy diSease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>chronic renal insufficiency ( creatinine clearance &lt; 60 ml/min , dialysis patient include ) least two significant ( &gt; 70 % ) coronary lesion two major coronary vessel . Age &gt; 85 year leave main coronary artery disease saphenous vein graft disease STelevation MI ( &lt; 3 day ) coronary vessel diameter &lt; 2.5 &gt; 4 mm contraindication longterm double antiplatelet therapy CABG indication consensus ( cardiovascular team ) severe valvular heart disease inform consent obtain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Percutaneous coronary intervention</keyword>
	<keyword>Drug-eluting stent</keyword>
	<keyword>Chronic kidney disease</keyword>
	<keyword>Restenosis</keyword>
</DOC>